JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Food-borne trematode infections of humans in the United States of America.

This review examines the literature on imported (allochthonous) and local (autochthonous) cases of food-borne trematode (FBT) infections in the United States of America (USA) from 1890 to 2009. Most of the literature is concerned with imported cases of the opisthorchiids Clonorchis sinensis and Opisthorchis viverrini. These flukes cause serious pathology in the liver and biliary system of humans. Chronic cases may induce liver (hepatocarcinoma) and bile duct (cholangiocarcinoma) cancers in humans. Clonorchiasis and opithorchiasis are preventable diseases that can be avoided by eating properly cooked freshwater fish products. Several species of lung flukes in the genus Paragonimus are local or imported FBT in the USA. The endemic cycle occurs in the USA with various local snails and crustaceans serving as intermediate hosts. Paragonimids are acquired when humans eat raw or improperly cooked freshwater crustaceans containing metacercarial cysts. Infection can cause severe lung disease and the symptoms of paragonimiasis often mimic those of tuberculosis and other non-helminthic diseases. Paragonimiasis can be avoided by not eating raw or improperly cooked shellfish. The liver fluke Fasciola hepatica can be acquired by eating raw or uncooked vegetation. The cycle exists in the USA involving local snails and aquatic vegetation. Although some cases are local, most are imported by travelers or immigrants. Fascioliasis can cause serious liver and biliary diseases in humans and consumption of tainted vegetation should be avoided. Lesser known FBT have been reported in the USA including species of Alaria, echinostomids, heterophyids, troglotrematids, and a self-induced infection of Plagiorchis. Treatment of the FBT mentioned in this review consists of various regimens of praziquantel, except for F. hepatica where the drug of choice is triclabendazole.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app